Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shandong Luye Pharmaceutical
Shandong Luye Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Rykindo
Risperidone
2023-01-13
2025-2033
Dementia
,
Tourette syndrome
,
Schizophrenia
,
Bipolar disorder
,
Autistic disorder
,
Schizophrenia spectrum and other psychotic disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Albumin
overactive urinary bladder
,
urinary incontinence
,
urinary bladder diseases
,
enuresis
,
aging
Toludesvenlafaxine
depression
,
major depressive disorder
,
depressive disorder
Glycididazole
carcinoma
,
esophageal neoplasms
,
squamous cell carcinoma
Taxane
vomiting
,
nausea
,
castration-resistant prostatic neoplasms
,
carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
prostatic neoplasms
,
non-small-cell lung carcinoma
,
squamous cell carcinoma
,
recurrence
,
fallopian tube neoplasms
,
hepatitis b
,
whooping cough
,
herpes zoster
,
mumps
,
tetanus
,
diphtheria
,
measles
,
haemophilus infections
,
chickenpox
,
poliomyelitis
,
rubella
,
lung neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use